Should You Buy AbbVie Stock Before Oct. 30?
The healthcare company will release its third-quarter numbers later this month.
Overview
AbbVie (NYSE:ABBV) is a top healthcare company that's been doing well this year, rising by 17% in value, which is better than the S&P 500 and its gains of around 14%. It's been beating the market, and what could send its shares even higher is a strong earnings report for the third quarter.
In a few weeks, on Oct. 30, AbbVie will release its Q3 numbers. Here's why investors may want to consider buying the healthcare stock before then.
Image source: Getty Images.
Details
Source
Originally published at www.fool.com.
Related Articles
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.